CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 162924-163062 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1284","span":{"begin":0,"end":138},"obj":"Sentence"},{"id":"T68538","span":{"begin":0,"end":138},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several new compounds have recently entered clinical use that show improved tolerability profile or activity against drug resistant virus."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T148","span":{"begin":0,"end":138},"obj":"Sentence"}],"text":"Several new compounds have recently entered clinical use that show improved tolerability profile or activity against drug resistant virus."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T139","span":{"begin":117,"end":131},"obj":"Phenotype"}],"attributes":[{"id":"A139","pred":"hp_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/HP_0020174"}],"text":"Several new compounds have recently entered clinical use that show improved tolerability profile or activity against drug resistant virus."}